Antibodies against CCR5 and uses thereof

Details for Australian Patent Application No. 2006228663 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Schumacher, Ralf; Sankuratri, Suryanarayana; Seeber, Stefan; Brandt, Michael

Agent Spruson & Ferguson

Pub. Number AU-A-2006228663

PCT Pub. Number WO2006/103100

Priority 05007138.0 01.04.05 EP

Filing date 31 March 2006

Wipo publication date 5 October 2006

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/103100 Priority application(s): WO2006/103100

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228664-Means for the inhibition of anti-beta1adrenergic receptor antibodies

2006228654-Enhanced delivery of skin benefit agents